https://www.selleckchem.com/pr....oducts/pclx-001-ddd8
ices are largely consistent with the 2009 guideline recommendations. Variations in vancomycin dosing and monitoring protocols are identified, and rationale for guideline non-adherence with loading doses elucidated. To evaluate the association of sociodemographic, clinical, and pathological factors with response and survival in triple negative breast cancer (TNBC) undergoing neoadjuvant chemotherapy (NACT). Clinical-pathological and sociodemographic data were obtained from medical records of 235 eligible women with TNBC diagnos
Like
Comment
Share
